These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 19148581
41. H-Ras regulation of TRAIL death receptor mediated apoptosis. Chen JJ, Bozza WP, Di X, Zhang Y, Hallett W, Zhang B. Oncotarget; 2014 Jul 15; 5(13):5125-37. PubMed ID: 25026275 [Abstract] [Full Text] [Related]
42. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation. Sonnemann J, Trommer N, Becker S, Wittig S, Grauel D, Palani CD, Beck JF. Cancer Biol Ther; 2012 Apr 15; 13(6):417-24. PubMed ID: 22313685 [Abstract] [Full Text] [Related]
43. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK. Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688 [Abstract] [Full Text] [Related]
44. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells. Kong F, You H, Zhao J, Liu W, Hu L, Luo W, Hu W, Tang R, Zheng K. Virol J; 2015 Nov 17; 12():192. PubMed ID: 26577955 [Abstract] [Full Text] [Related]
48. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis. Song JH, Kandasamy K, Kraft AS. J Biol Chem; 2008 Sep 05; 283(36):25003-13. PubMed ID: 18599488 [Abstract] [Full Text] [Related]
49. DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design. Tur V, van der Sloot AM, Reis CR, Szegezdi E, Cool RH, Samali A, Serrano L, Quax WJ. J Biol Chem; 2008 Jul 18; 283(29):20560-8. PubMed ID: 18474604 [Abstract] [Full Text] [Related]
50. Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis. Szliszka E, Zydowicz G, Mizgala E, Krol W. Int J Oncol; 2012 Sep 18; 41(3):818-28. PubMed ID: 22735465 [Abstract] [Full Text] [Related]
51. Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts. Yeh CC, Ko HH, Hsieh YP, Wu KJ, Kuo MY, Deng YT. Clin Oral Investig; 2016 Dec 18; 20(9):2343-2352. PubMed ID: 26822174 [Abstract] [Full Text] [Related]
52. Overexpressed TP73 induces apoptosis in medulloblastoma. Castellino RC, De Bortoli M, Lin LL, Skapura DG, Rajan JA, Adesina AM, Perlaky L, Irwin MS, Kim JY. BMC Cancer; 2007 Jul 12; 7():127. PubMed ID: 17626635 [Abstract] [Full Text] [Related]
53. Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells. Oh Y, Jeon YJ, Hong GS, Kim I, Woo HN, Jung YK. Cell Death Differ; 2012 Jul 12; 19(7):1196-207. PubMed ID: 22240897 [Abstract] [Full Text] [Related]
54. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells. Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS. Apoptosis; 2010 Oct 12; 15(10):1256-69. PubMed ID: 20582477 [Abstract] [Full Text] [Related]
55. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death. Nguyen DM, Yeow WS, Ziauddin MF, Baras A, Tsai W, Reddy RM, Chua A, Cole GW, Schrump DS. Cancer J; 2006 Oct 12; 12(4):257-73. PubMed ID: 16925970 [Abstract] [Full Text] [Related]
56. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ. Oncol Rep; 2007 Jan 12; 17(1):175-84. PubMed ID: 17143496 [Abstract] [Full Text] [Related]
58. Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis. Abdulghani J, Allen JE, Dicker DT, Liu YY, Goldenberg D, Smith CD, Humphreys R, El-Deiry WS. PLoS One; 2013 Jan 12; 8(9):e75414. PubMed ID: 24086526 [Abstract] [Full Text] [Related]
59. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells. Hu JK, Yang K, Li CM, Zhang B, Chen ZX, Chen XZ, Chen JP. Oncol Rep; 2009 Mar 12; 21(3):681-8. PubMed ID: 19212626 [Abstract] [Full Text] [Related]
60. Anti-tumor Effects of IL-1β Induced TRAIL-Expressing hUCMSCs on Embelin Treated Breast Cancer Cell Lines. Teng JW, Hung E, Wu JM, Liang YH, Chiu YH, Tyan YS, Wang HS. Asian Pac J Cancer Prev; 2023 Apr 01; 24(4):1297-1305. PubMed ID: 37116152 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]